This is a collection of papers presented at a prostate cancer symposium held in Quebec City in September 1995. The editorial that serves as a preface for the book implies that this is a comprehensive discussion of advances in the treatment of prostate cancer. However, this is a publication for the Society of Endocrinology and the clear focus is on hormonal aspects of treatment. There is no precisely defined focus for the book and there is not any real continuity between the articles. There is no apparent effort to provide a balance of opinions. The editors do not describe the audience for which this book is intended. However, it would only be useful for individuals with a deep understanding of the subject matter as there are considerable biases of the editors and authors that must be recognized in order to maintain an appropriate perspective. The book is a series of short articles, most of which do not deal in any comprehensive manner with the subject matter. There are very few illustrations. The tables and graphs are typical of those which would be found in a scientific article. The bibliography is selective and not comprehensive. This book serves primarily as a forum for the editors to promote their biases on prostate cancer treatment, especially those related to endocrine therapy. There is great controversy and considerable disagreement among experts about the validity of some of the observations expressed in this book. However, there is no effort to present a balanced approach or even to acknowledge the controversy. This limits the value of this text.
A collection of 14 papers originally published in "Endocrine-Related
Cancer", Vol. 3, No. 3, 1996, sharing new discoveries in the area of
prostate cancer and treatment. The contributors present clinical
findings in combination radiation and hormone therapies, neoadjuvant
androgen ablation therapy prior to radical prostatectomy, antigen
screening, the economic implications of prostate cancer screening,
neoadjuvant hormonal deprivation, studies in Flutamide and Casodex,
and the history of LHRH agonist and combination therapy. Lacks an
index. Distributed by Blackwell Science.
Annotation c. by Book News, Inc., Portland, Or.